Quote Budigalimab
Budigalimab (ABBV 181; PR 1648817) is a humanized IgG1 monoclonal antibody targeting programmed cell death 1 (PD-1) receptor. Budigalimab is Fc mutated thus to reduce Fc receptor interactions and limit effector function.
Read more
€0.00
(tax incl.)
Reference:
HY-P99489
Brand: